10 Medical Devices companies are scored. Their average composite is 61.9, and 0 are in the A range (76+). The leader is DexCom Inc. (DXCM) at 70.3 (B+). This industry belongs to the Healthcare sector.
| # | Company | Composite | Grade | Industry opportunity | Stock selection | KPI momentum | Catalyst watch | Price | Expansion | Quality | Trend | Valuation gap |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DexCom Inc. (DXCM) | 70.3 | B+ | 77 | 85 | 87 | 73 | 44 | 81 | 74 | 51 | -25.0% |
| 2 | Edwards Lifesciences Corp. (EW) | 64.0 | B- | 77 | 79 | 81 | 80 | 27 | 68 | 69 | 41 | +1.7% |
| 3 | STERIS plc (STE) | 63.9 | B- | 77 | 78 | 69 | 75 | 48 | 54 | 48 | 29 | -7.7% |
| 4 | Zimmer Biomet Holdings Inc. (ZBH) | 62.9 | B- | 77 | 71 | 62 | 78 | 80 | 38 | 46 | 37 | -12.1% |
| 5 | Medtronic Plc (MDT) | 62.7 | B- | 77 | 78 | 76 | 81 | 59 | 44 | 46 | 43 | -5.9% |
| 6 | Abbott Laboratories (ABT) | 60.9 | B- | 77 | 87 | 86 | 77 | 49 | 49 | 46 | 25 | -6.4% |
| 7 | GE HealthCare Technologies Inc. (GEHC) | 60.5 | B- | 77 | 80 | 81 | 73 | 66 | 38 | 37 | 27 | -5.8% |
| 8 | Stryker Corp. (SYK) | 59.3 | B- | 77 | 84 | 88 | 73 | 45 | 63 | 57 | 12 | -3.3% |
| 9 | Insulet Corp. (PODD) | 59.2 | B- | 77 | 70 | 54 | 69 | 48 | 84 | 55 | 3 | -18.8% |
| 10 | Boston Scientific Corp. (BSX) | 55.7 | C+ | 77 | 70 | 62 | 68 | 69 | 53 | 55 | 6 | -17.4% |
The composite score (0–100, graded A+ to D-) blends research signals from each earnings call with fundamental lenses from SEC filings and market prices. Research signals: Industry opportunity, Stock selection, KPI momentum and Catalyst watch, read from what management said and whether it delivered. Fundamental lenses: Price (valuation), Expansion (growth), Quality (profitability) and Trend (momentum). Scores are recalculated every night and after every earnings call. The valuation gap compares the actual price path with the path the stock's market, sector and industry moves explain; it is a model comparison, not a fair-value estimate.
General information, not investment advice.